Teams should treat tracking as a baseline, not a control boundary. Production governance needs pre-release behavioural testing, runtime policy enforcement, and audit evidence that shows whether unsafe outputs were prevented, not merely recorded. If the AI system can expose data, trigger actions, or influence decisions, those controls must sit alongside experiment tracking.
Why MLflow Is Necessary but Not Sufficient for GenAI Governance
MLflow is useful for traceability, but it is not the full governance layer for a GenAI system. Tracking runs, prompts, or model versions tells you what changed, not whether the system is safe to release or safe to operate. A governed GenAI programme needs controls that test behaviour before deployment and constrain behaviour after deployment, especially when outputs can affect data, decisions, or actions.
That distinction matters because a recorded experiment can still be unsafe in production. Teams need to separate development observability from operational approval, then prove that the system was assessed against abuse, leakage, hallucination, and action-taking risks before it was allowed to interact with real users or real tools.
What Proper GenAI Governance Adds Beyond Experiment Tracking
Production governance usually adds three layers that MLflow does not provide on its own. First is pre-release validation, where teams test for unsafe content, prompt injection exposure, harmful tool use, and policy violations. Second is runtime enforcement, where policy checks, guardrails, authorization, or output filtering stop disallowed behaviour while the system is live. Third is auditability, where evidence shows what was tested, what was blocked, and what exceptions were approved.
If the GenAI system is only producing low-risk summaries, tracking may be enough for development hygiene but not for release confidence. If it can expose data, call tools, create tickets, send messages, or influence business decisions, governance must cover both the model behaviour and the downstream effect of that behaviour. That is the point where a model registry becomes only one input into a wider control set.
For teams using external reference points, the governance model for GenAI is well captured by the NIST AI 600-1 GenAI Profile, which emphasises pre-deployment testing, risk management, and lifecycle controls. Broader programme structure is also reinforced by the NIST AI Risk Management Framework and the ISO/IEC 42001:2023 AI Management System Standard, both of which treat governance as a managed process, not a logging exercise.
How to Decide Whether Tracking Is Enough, and When It Is Not
A practical decision rule is simple: if the system can only be inspected after the fact, tracking is incomplete. If the system can affect outcomes in production, you need preventative and detective controls in front of, alongside, and after the model. That includes release gates, approval thresholds, prompt and output policies, human review for sensitive actions, and monitoring that can tell you when the system behaves outside the intended envelope.
Teams should also be clear about evidence. A useful governance record does not just show that an experiment was run. It shows that relevant test cases were executed, failure modes were reviewed, policy exceptions were approved, and runtime controls were enabled before exposure. Without that evidence, it is hard to distinguish a well-managed rollout from a well-documented risk.
Where the system has tool access, cross-service access, or automated decision impact, the control set starts to resemble OWASP Agentic AI Top 10 concerns rather than simple model operations. For teams that govern access to non-human actors more broadly, the OWASP Non-Human Identity Top 10 is also a useful reminder that credentials, privilege, and offboarding matter when AI systems are allowed to act.
Risk and Threat Considerations
Tracking-only governance creates a blind spot: it records what the model did during experimentation but does not prevent unsafe behaviour in production. That leaves organisations exposed to data leakage, policy bypass, harmful tool invocation, and decisions made on outputs that were never properly validated under realistic conditions.
Failure mechanism: The system is treated as governed because its experiments are versioned, while the live path lacks enforced policy, release testing, or exception control. An attacker, a malformed prompt, or an ordinary edge case can then push the model into producing disallowed outputs or taking unsafe actions.
Impact: Sensitive data can be exposed, business workflows can be manipulated, and audit evidence can become misleading because it proves recording, not prevention. In higher-risk environments, that can turn a model issue into an operational, compliance, or trust incident.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Agentic AI Top 10 and OWASP Non-Human Identity Top 10 address the attack surface, NIST AI 600-1 and NIST AI RMF set the technical controls, and ISO/IEC 42001:2023 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST AI 600-1 | Generative AI Profile | GenAI governance needs pre-deployment testing and lifecycle risk controls. |
| Recommendation — Apply GenAI profile controls to test unsafe behaviour before release and manage runtime risk. | ||
| NIST AI RMF | AI Risk Management Framework | The question is about managing AI risk beyond tracking and versioning. |
| Recommendation — Use AI RMF functions to govern, measure, and monitor GenAI risk across its lifecycle. | ||
| ISO/IEC 42001:2023 | AI management system | GenAI governance requires an organisational management system, not only experiment tracking. |
| Recommendation — Establish AI management processes that define approval, monitoring, and accountability. | ||
| OWASP Agentic AI Top 10 | ASI03 — Identity & Privilege Abuse | GenAI systems that can act on tools or decisions need controls against misuse of authority. |
| Recommendation — Restrict agent privileges and validate actions before allowing production tool access. | ||
| OWASP Non-Human Identity Top 10 | NHI-05 — Overprivileged NHI | AI systems with production access can become overprivileged non-human actors. |
| Recommendation — Review AI credentials and remove excess privilege before production deployment. | ||
Practitioner Guidance
What to prioritise: Treat MLflow as an observability input, then define the release gate separately. The first governance question is not “was the model tracked?” but “was unsafe behaviour tested and blocked before production use?”
What to verify: Confirm that pre-release test cases cover prompt injection, sensitive data exposure, tool misuse, and policy-boundary failures. Then verify that runtime controls are actually enforced in the live path, not just documented in the design.
Practitioner takeaway: A GenAI system is not governed when it is merely reproducible; it is governed when its risky behaviours are both tested before release and constrained during operation.